Mechanisms of Disease: hepatic steatosis in type 2 diabetes—pathogenesis and clinical relevance

Excess free fatty acids, an imbalance of adipocytokines and mitochondrial dysfunction all contribute to abnormalities in hepatocellular lipid content in diabetes and can lead to steatosis and insulin resistance. Thus liver fat is a novel target for therapies such as fat-reduced diets and thiazoliden...

Celý popis

Uloženo v:

Podrobná bibliografie
Vydáno v:	Nature clinical practice. Endocrinology & metabolism Ročník 2; číslo 6; s. 335 - 348
Hlavní autor:	Roden, Michael
Médium:	Journal Article
Jazyk:	angličtina
Vydáno:	London Nature Publishing Group UK 01.06.2006 Nature Publishing Group
Témata:	Diabetes Diabetes Mellitus, Type 2 - complications Diabetes Mellitus, Type 2 - drug therapy Diabetes Mellitus, Type 2 - physiopathology Endocrinology Fatty acids Fatty Acids, Nonesterified - metabolism Fatty Liver - drug therapy Fatty Liver - etiology Fatty Liver - metabolism Gastroenterology Glucose Humans Hypoglycemic Agents - pharmacology Hypoglycemic Agents - therapeutic use Insulin resistance Insulin Resistance - physiology Kinases Lipids Liver - drug effects Liver - metabolism Liver - pathology Liver cirrhosis Liver diseases Medicine Medicine & Public Health Metabolism Models, Biological Nephrology Nutrients Oils & fats review-article Triglycerides
ISSN:	1745-8366, 1759-5029, 1745-8374, 1759-5037
On-line přístup:	Získat plný text
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!

Buďte první, kdo okomentuje tento záznam!